support@activebiopharma.com
中文版
Menu
Home
Products
Inhibitors
AKT Inhibitors
ALK Inhibitor
ATM Inhibitor
Aurora Kinase Inhibitors
Bcl-2 Protein Family Inhibitors
B-Raf inhibitors
CDK inhibitors
c-Met Inhibitors
EGFR inhibitor
HDAC Inhibitors
Hedgehog inhibitor
HIV Inhibitor
JAK inhibitor
MEK inhibitor
mTOR Inhibitor
PARP inhibitor
PI3K Inhibitor
PKC Inhibitor
PLK1 Inhibitor
Other inhibitors
Activator
Agonist
antagonist
API
Aurora
Metabolic Disease
VEGFR-PDGFR
Other Intermediate
Others
MOF Chemicals
About Us
Custom Synthesis
Order & Payment
Contact Us
Name Index V
Home
/
Name Index V
Cas Index
1
2
3
4
5
6
7
8
9
Name Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
CAS
Chemical Name
Cat.No.
MolFormula
38074-72-5
Vildagliptin Impurity 13
ABP013031
C8H12ClNO3
1803168-09-3
Vildagliptin Impurity R
ABP013029
800408-39-3
VX-166
ABP012207
896720-20-0
VX-11e
ABP012206
C16H13ClFN5O
409351-28-6
VU0152100
ABP012205
C18H19N3O2S
893990-34-6
VU 0240551
ABP012202
C16H14N4OS2
1264191-73-2
VTP-27999 (Hydrochloride)
ABP012201
C26H41ClN4O5.ClH
942142-51-0
VTP-27999
ABP012199
C26H41ClN4O5
1375603-36-3
VT-464 (racemate)
ABP012198
1375603-38-5
VT-464 (R enantiomer)
ABP012197
1610537-15-9
VT-464
ABP012196
960203-27-4
Vortioxetine (hydrobromide)
ABP012193
C18H22N2S.BrH
175519-16-1
Voreloxin (Hydrochloride)
ABP012189
C18H19N5O4S.ClH
175414-77-4
Voreloxin
ABP012188
C18H19N5O4S
476310-60-8
VO-Ohpic (trihydrate)
ABP012187
C12H8N2O7V.3H2O
1209002-43-6
VMY 1-103
ABP012184
479-91-4
Vitexicarpin
ABP012183
C19H18O8
43119-47-7
VitaMin E nicotinate
ABP012182
C35H53NO3
511-28-4
Vitamin D4
ABP012181
C28H46O
1085703-32-7
VITAMIN CK3
ABP012180
C11H8O2.C6H8O6
68-19-9
Vitamin B12
ABP012179
C63H88CoN14O14P
742092-03-1
Vintafolide
ABP012177
C86H109N21O26S2
42971-09-5
Vinpocetine
ABP012176
C22H26N2O2
« Pre
1
2
3
4
5
6
7
8
9
10
Next »
Cas Index
1
2
3
4
5
6
7
8
9
Name Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Copyright © 2015-2025 Active Biopharma Corp. All rights reserved. Support by
Moldb
.
浙ICP备11021315号-3
浙公网安备 33010802003999号
Scroll